Health
New antitumor vaccines control melanoma growth in preclinical models – News-Medical.Net
Combining their expertise in protein engineering and synthetic DNA technology, scientists at The Wistar Institute successfully delivered nanoparticle antitumor vaccines that stimulated robust CD8 T cell immunity and controlled melanoma growth in preclinical m…
Reviewed by Emily Henderson, B.Sc.Sep 11 2020
Combining their expertise in protein engineering and synthetic DNA technology, scientists at The Wistar Institute successfully delivered nanoparticle antitumor vaccines that stimulated robust CD8 T cell immunity and controlled melanoma growth in preclinical models.
Study results were published online in Cancer Immunology Research, a journal of the American Association for Cancer Research, and support exploration of this immunotherapy approach for a…
-
General20 hours agoFour charged over alleged six-hour gang rape of girl in south-west Sydney
-
Business10 hours ago3 of the best ASX stocks to buy now with $2,500
-
Noosa News22 hours agoLogan City Council to pull out of federal government Climate Active program due to financial pressure, transparency concerns
-
Business23 hours agoAiming for rock-solid retirement income? I’d buy these two ASX shares